Skip to main content

Select Drug Profiles

Multiple Myeloma, Oncology

FIRST Trial Shows Value for Continued Use of Lenalidomide in Transplant-Ineligible Patients with Newly Diagnosed Myeloma

Caroline Helwick

Leukemia, Oncology

Nilotinib Sustains Deeper Molecular Response versus Imatinib in Patients with Ph+ CML

Novel CAR-T Therapy Topped the News at ASH 2013

Caroline Helwick

Leukemia, Oncology

Novel Anti-CD20 Antibodies Show Promising Results in Unfit Patients with Chronic Lymphocytic Leukemia

Rituximab Infusions Costlier When Given in the Hospital

Hematologists Urged to Reduce Unnecessary Tests/Procedures, and Costs to Improve Quality of Care

Caroline Helwick

Peripheral T-Cell Lymphoma Associated with High Clinical Burden, Resource Utilization, and Costs

Significant Hospital Costs Tied to 30-Day Readmissions for Allogeneic Transplants

Physicians Must Consider the Financial Burden of Allogeneic Transplants

Clinical Practice Guidelines Should Include Patient’s Preferences

Page 159 of 244
Results 1581 - 1590 of 2438